ICRS and Elsevier Launch New Journal

The International Cartilage Regeneration & Joint Preservation Society (ICRS) and Elsevier partner to create a new peer-reviewed open-access journal that will focus on whole joint health and support the cartilage community.


The International Cartilage Regeneration & Joint Preservation Society (ICRS), the main forum for international collaboration in cartilaginous tissue research and joint preservation, and Elsevier, a global research publishing and information analytics provider, today announced the launch of a new open access journal, The Journal of Cartilage & Joint Preservation (JCJP) beginning December 4, 2021.

Founded in 1997 in Switzerland, with more than 1,300 active members from 65 countries, the ICRS brings together basic scientists, clinical researchers, physicians, other healthcare providers and members of industry, engaged or interested in the field of articular biology, its genetic basis and regenerative medicine. The Society’s partnership with Elsevier to create a new open access publication will support its mission to advance science and education of the prevention and treatment of cartilage diseases worldwide.

“We are excited about launching a new open access journal which will expand the reach of the most important research in cartilage and will be compliant with cOAlition S requirements in 2021,” said ICRS President Tom Minas, MD, Orthopaedic Surgeon at the Paley Orthopedic and Spine Institute in West Palm Beach, Florida, and Professor Emeritus of Orthopaedic Surgery at Harvard Medical School. “This new journal will publish ICRS state of the art articles and will offer authors the opportunity to publish case series, review articles and video technique articles in a timely peer-reviewed manner.”

The ICRS and Elsevier are committed to a rigorous editorial process, led by Editor in Chief Lisa A. Fortier, DVM, PhD, and her diverse editorial board. Fortier noted that this new journal is unique among medical journals with a focus on whole-joint health, which seamlessly aligns with the mission of the ICRS and envisions JCJP achieving a worldwide prominence in the field.

Elsevier Publisher Ginny Pittman commented, “We are delighted that the ICRS has selected Elsevier as its publishing partner for their new open access journal. Elsevier supports cartilage research dissemination through our extensive journal portfolio and JCJP will offer authors a quick, reliable, and high-impact outlet for their work. We will provide the editorial team with tools to ensure a rapid review and publication timeline, so authors can receive a publication decision and their research can be fast-tracked for online discovery.”

The journal will be able to take advantage of additional reach and capabilities offered by Elsevier as a top-tier publisher, with a suite of robust resources for authors, industry-leading platform technology, sophisticated analytics and services, and maximized dissemination of content.

About The International Cartilage Regeneration & Joint Preservation Society 

The International Cartilage Regeneration & Joint Preservation Society (ICRS) envisages the scientific research and the exchange of knowledge among physicians, scientists, patients and researchers of the industry in the field of Cartilage Regeneration & Joint Preservation. The society seeks to improve patients´ quality of life, decrease their disability and reduce the impact of degenerative joint disease on healthcare systems worldwide by preserving joints and maintaining function. ICRS publishes Cartilage (https://journals.sagepub.com/home/car) and The Journal of Cartilage & Joint Preservation (www.cartilagejournal.org), an online, peer-reviewed open access journal.

About Elsevier and Society Partnerships

Elsevier has long partnership records with over 600 learned scientific societies and works with organizations worldwide to support them in their mission of education support of the scientific communities.

About Elsevier

Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray’s Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

Trending Articles
EHV-1 Confirmed at New York Racetrack
Florida Horse Tests Positive for EEE
3 Wisconsin Horses Positive for EHV
Oklahoma Quarter Horse Positive for EHM
Get the best from EquiManagement delivered straight to your inbox once a week! Topics include horse care, disease alerts, and vet practitioner updates.

"*" indicates required fields


Additional Offers

This field is for validation purposes and should be left unchanged.